Biotest AG (BIO.DE)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
40.80
0.00 (0.00%)
At close: Feb 07, 2025, 11:26 AM
undefined% (undefined)
Bid | n/a |
Market Cap | 1.38B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 1.73 |
PE Ratio (ttm) | 23.58 |
Forward PE | n/a |
Analyst | n/a |
Ask | n/a |
Volume | 145 |
Avg. Volume (20D) | 79 |
Open | 40.80 |
Previous Close | 40.80 |
Day's Range | 40.80 - 40.80 |
52-Week Range | 40.60 - 43.00 |
Beta | undefined |
About BIO.DE
Biotest Aktiengesellschaft develops, manufactures, and sells biological medicines in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers its products in hematology, clinical immunology, and intensive care medicine areas. Its products include Haemoctin and Vihuma for the treatment of haemophilia A acute therapy and prophylaxis; and Haemonine for haemophilia B acute therapy and prophyl...
Industry Biotechnology
Sector Healthcare
IPO Date Nov 19, 1998
Employees 2,464
Stock Exchange XETRA
Ticker Symbol BIO.DE
Website https://www.biotest.com